Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May;59(9):1146-1147.
doi: 10.1111/apt.17966.

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply

Affiliations
Editorial

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply

Benedikt Silvester Hofer et al. Aliment Pharmacol Ther. 2024 May.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Verhelst X. Editorial: recompensation in PBC is good. But is it good enough? Aliment Pharmacol Ther. 2024;59:1144–1145.
    1. Hofer BS, Simbrunner B, Burghart L, Halilbasic E, Petrenko O, Mandorfer M, et al. Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Aliment Pharmacol Ther. 2024;59:962–972.
    1. de Franchis R, Bosch J, Garcia‐Tsao G, Reiberger T, Ripoll C, Baveno VII Faculty. Baveno VII – renewing consensus in portal hypertension. J Hepatol. 2022;76:959–974.
    1. Harms MH, van Buuren HR, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, et al. Ursodeoxycholic acid therapy and liver transplant‐free survival in patients with primary biliary cholangitis. J Hepatol. 2019;71:357–365.
    1. Hofer BS, Simbrunner B, Hartl L, Jachs M, Balcar L, Paternostro R, et al. Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis. Liver Int. 2023;43:2220–2231.

LinkOut - more resources